Compare MGPI & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGPI | SLDB |
|---|---|---|
| Founded | 1941 | 2013 |
| Country | United States | United States |
| Employees | 267 | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 397.4M | 498.6M |
| IPO Year | 1994 | 2017 |
| Metric | MGPI | SLDB |
|---|---|---|
| Price | $19.37 | $8.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $30.00 | $16.36 |
| AVG Volume (30 Days) | 245.8K | ★ 1.0M |
| Earning Date | 04-30-2026 | 05-14-2026 |
| Dividend Yield | ★ 2.56% | N/A |
| EPS Growth | N/A | ★ 34.97 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,782,000.00 | $8,094,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.11 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.45 | $2.45 |
| 52 Week High | $33.75 | $8.47 |
| Indicator | MGPI | SLDB |
|---|---|---|
| Relative Strength Index (RSI) | 53.03 | 62.83 |
| Support Level | $18.00 | $5.16 |
| Resistance Level | $26.44 | $8.47 |
| Average True Range (ATR) | 0.81 | 0.62 |
| MACD | 0.32 | 0.08 |
| Stochastic Oscillator | 94.90 | 86.18 |
MGP Ingredients Inc is a producer and supplier of distilled spirits, specialty wheat protein, and starch food ingredients based in the United States. It operates in three reportable segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Maximum revenue is generated from the Branded Spirits segment, which consists of a portfolio of brands that it produces through its distilleries and bottling facilities and sells to distributors or to state governments that directly control the sale of alcohol. MGP's branded spirits include various brands across numerous categories and price tiers, such as Penelope Bourbon, Yellowstone Bourbon, Minor Case Straight Rye Whiskey, Brady's Irish Cream, Exotico Tequila, Arrow Cordials, Canada House Canadian Whisky, Lady Bligh Rum, etc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.